Updated 18:04 GMT, 28 Oct 2026 SPX 7,737.41 +0.19% NDX 29,708.81 +0.19% VIX 17.29 -1.31% GOLD 4,052.60 -0.54% CL 102.63 +2.73% BTC 80,941.90 +0.17%
NAS100 29,709 +0.19% S&P 7,737 +0.19% GOLD $4,053 −0.54% BTC $80,942 +0.17% VIX 17.29 −1.31% latest tape · as of 18:04 UTC
The Screen · Consumer Defensive

Youdao, Inc. logoYoudao, Inc.

DAO · the NYSE · USD · Market cap $2.3B

FAIL · Does not pass the screen
19.00 USD

Price as of 27 Oct 2026Daily close, not a live quote

Screened 2026-10-27 · the tape above runs as of 18:04 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price19.00 USD at the 27 Oct 2026 close
  • Our ratingAvoid, current read accumulation
  • Ethical screenDoes not pass
  • OptionsOpen interest leans heavily to calls (put/call 0.23)
  • Last reviewed27 Oct 2026 (1 days ago)

A summary of the dated readings below, not a live quote and not advice.

PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y
11.2614.8817.11

What this means: price 19.00 against the desk's fair-value range, base estimate 14.88, over the last year.

Current read
Accumulation ?
AVOID · screened 2026-10-27
  • Trend Accumulation
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options put/call open interest 0.23, read 2026-10-25
  • Ethical does not pass the values gate
Price19.00 USD
Fair value14.88
RatingAVOID
Our investment reviews on this name
2026-10-11Read Accumulation14.56+30.5% to today ✓Markdown gives way to Accumulation with volume flow in agreement
2026-10-02Read Markdown14.56+30.5% to today Markup gives way to Markdown after a 25% rise in 13 weeks
2026-07-02Read Markup11.66+63.0% to today ✓First review on file: Markup

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its accumulation label.

Youdao, Inc. holds its Accumulation at $19.00. The statistical read favours the sellers, held for 47 days.

As held on the ledger · 2026-10-27
PhaseAccumulation
Quantitative stateThe statistical read favours the sellers, held for 47 days
Price at the screen$19.00
Valuation100.00 trailing · 43.44 forward price to earnings
Values screenFAIL
Beta0.52
The Workings

Five Screens, Shown in Full

Does not pass. Debt ratio

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 129.12% Below 33% Interest-bearing debt is 129.1% of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash 51.63% Below 33% Interest-bearing cash and securities are 51.6% of assets, above the one-third limit. Fail
Receivables 0.00% Below 49% Money owed to the company is 0.0% of assets, under the 49% limit. Pass
Revenue purity 0.04% Below 5% Only 0.0% of revenue comes from non-compliant sources, under the 5% line. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

Youdao,'s business is in a permissible area, but its interest-bearing debt is about 129% of the company, well over the ~33% line, so it does not pass on the financial screens.

Read as at 2026-10-27. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when DAO's ethical verdict changes

Today DAO does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads AVOID: it trades above our $14.88 fair value estimate, weak competitive moat, 3.50% revenue growth.

11.26Conservative14.88Base case17.11Growth case 19.00Price

Fair value range in USD, drawn from the 2026-10-27 screen. The gold marker is the market price at the same screen. The price runs 21.7% above the base estimate.

The Street's Range
12.52Street low 21.01Street average 24.40Street high 19.00Price

Third-party analyst targets: 6 covering, consensus None. The average target sits +11% from the screen price.

Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.

Price History & Projections
$26.4$14.2$2.0TODAY5y agoPROJECTIONStreet high$24.40 +104%Street avg$21.01 +75%Our fair value$14.88 +24%Conservative$11.26 -6%

Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-27 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Edtech Platform Carries Heavy Debt And Thin Returns

Every student tapping a Chinese learning app expects quick results, yet Youdao shows revenue growing just 4% with profit margins stuck at 1%. The business trades at 34.5 times forward earnings while our fair value sits 23% below the current price, so the numbers point to an overpriced name with a weak moat. We pass because the setup fails both valuation discipline and the ethical screen on debt.

The market already prices in modest improvement, but low growth and slim margins leave little room for error when competition intensifies. A single analyst target near the current level does not change the fact that earnings power looks limited for the multiple paid.

Debt levels trip the ethical screen outright, adding balance-sheet fragility on top of already thin returns. This combination of stretched valuation and governance concerns makes the risk profile unattractive. Analysis, not advice.

The fundamentals · plain-English read
Forward P/E43.4xexpensive even after accounting for its growth
Trailing P/E100.0xexpensive: the price assumes strong growth ahead
EPS, trailing0.19
EPS, forward0.44
Revenue growth+3.5%slow but positive growth
Profit margin2.7%barely profitable
Current ratio0.58below 1: short-term bills exceed liquid assets
Beta0.52steadier than the market
Short interest, float0.03%
52-week range8.38 - 19.81
MoatWEAK
Market cap$2.3B

The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

DAO trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-10-25 Accumulation $18.51 +0.0% Entry 9

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 52% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 34%. Our forward projection puts the odds of a 10% gain over the next month near 41%. The street (7 analysts) rates it strong buy, with a mean price target of $13.

2026-10-18 Accumulation $18.51 +27.1% Entry 8

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 27.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 10% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 34%. Our forward projection puts the odds of a 10% gain over the next month near 41%. The street (7 analysts) rates it strong buy, with a mean price target of $13.

2026-10-11 Accumulation · changed $14.56 +0.0% Entry 7

The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 10% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 34%. Our forward projection puts the odds of a 10% gain over the next month near 41%. The street (7 analysts) rates it strong buy, with a mean price target of $13.

2026-10-02 Markdown · changed $14.56 -12.6% Entry 6

The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 12.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 10% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 34%. Our forward projection puts the odds of a 10% gain over the next month near 41%. The street (7 analysts) rates it strong buy, with a mean price target of $13.

2026-08-26 Markup $16.65 +14.4% Entry 5

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 14.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 10% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 34%. Our forward projection puts the odds of a 10% gain over the next month near 41%. The street (7 analysts) rates it strong buy, with a mean price target of $13.

2026-07-26 Markup $14.55 +24.8% Entry 4

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 24.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 10% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 34%. Our forward projection puts the odds of a 10% gain over the next month near 41%. The street (7 analysts) rates it strong buy, with a mean price target of $13.

2026-07-18 Markup $11.66 +0.0% Entry 3

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 10% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 34%. Our forward projection puts the odds of a 10% gain over the next month near 41%. The street (7 analysts) rates it strong buy, with a mean price target of $13.

2026-07-03 Markup $11.66 +0.0% Entry 2

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.

2026-07-02 Markup $11.66 Entry 1

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on DAO

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in DAO's Space

Screened names in the same industry · explore each on its own page.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $12.16 -1.5% · $985 -1.5%
2 months $9.72 +23.2% · $1,232 +23.2%
3 months $9.71 +23.3% · $1,233 +23.3%
6 months $8.88 +34.9% · $1,349 +34.9%
1 year $8.97 +33.5% · $1,335 +33.5%
2 years $3.72 +221.9% · $3,219 +221.9%
3 years $5.03 +138.1% · $2,381 +138.1%
5 years $24.76 -51.6% · $484 -51.6%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever DAO does next, these words stay.

Youdao, Inc. · DAO · Accumulation · $19.00
Recorded 2026-10-27 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.